IL86881A - Polysaccharides extracted from plants,their preparation and pharmaceutical compositions containing them - Google Patents

Polysaccharides extracted from plants,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL86881A
IL86881A IL86881A IL8688188A IL86881A IL 86881 A IL86881 A IL 86881A IL 86881 A IL86881 A IL 86881A IL 8688188 A IL8688188 A IL 8688188A IL 86881 A IL86881 A IL 86881A
Authority
IL
Israel
Prior art keywords
plants
preparation
pharmaceutical compositions
compositions containing
polysaccharides extracted
Prior art date
Application number
IL86881A
Other languages
English (en)
Other versions
IL86881A0 (en
Original Assignee
Guyomarc H Nutrition Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guyomarc H Nutrition Animale filed Critical Guyomarc H Nutrition Animale
Publication of IL86881A0 publication Critical patent/IL86881A0/xx
Publication of IL86881A publication Critical patent/IL86881A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/807—Poultry or ruminant feed
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/809—Food or edible material: processes, compositions, and products including harvesting or planting or other numerous miscellaneous processing steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL86881A 1987-07-10 1988-06-27 Polysaccharides extracted from plants,their preparation and pharmaceutical compositions containing them IL86881A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8709857A FR2617848B1 (fr) 1987-07-10 1987-07-10 Polysaccharides extraits, notamment, de vegetaux utiles comme medicaments et additifs alimentaires

Publications (2)

Publication Number Publication Date
IL86881A0 IL86881A0 (en) 1988-11-30
IL86881A true IL86881A (en) 1992-06-21

Family

ID=9353077

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86881A IL86881A (en) 1987-07-10 1988-06-27 Polysaccharides extracted from plants,their preparation and pharmaceutical compositions containing them

Country Status (10)

Country Link
US (2) US4948785A (de)
EP (1) EP0304347B1 (de)
JP (1) JPH0657721B2 (de)
AT (1) ATE98264T1 (de)
BR (1) BR8803442A (de)
DE (1) DE3886134T2 (de)
DK (1) DK377888A (de)
ES (1) ES2060666T3 (de)
FR (1) FR2617848B1 (de)
IL (1) IL86881A (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04141064A (ja) * 1990-10-03 1992-05-14 Sunamiya:Kk 薬膳調味液、薬膳調味料の製造方法
WO1998044005A1 (fr) * 1997-03-28 1998-10-08 The Kampou Foundation Substance pharmacologiquement active
US6214351B1 (en) 1999-08-27 2001-04-10 Morinda, Inc. Morinda citrifolia oil
US6254913B1 (en) 1999-08-27 2001-07-03 Morinda, Inc. Morinda citrifolia dietary fiber and method
US7244463B2 (en) * 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US7048952B2 (en) * 2002-05-21 2006-05-23 Morinda, Inc. Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US20070196527A1 (en) * 2006-02-23 2007-08-23 Jensen Claude J Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US20120237626A9 (en) * 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US7018662B2 (en) * 2001-04-17 2006-03-28 Morinda, Inc. Palliative effects of morinda citrifolia oil and juice
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
US20050106275A1 (en) * 2003-05-02 2005-05-19 Chen Su Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
US20050260291A1 (en) * 2004-03-10 2005-11-24 Palu Afa K Methods and compositions for reactivating acetylcholinesterase
US20060088611A1 (en) * 2004-09-01 2006-04-27 Paulus Wang Morinda citrifolia-based formulations and methods for weight management
US20060141076A1 (en) * 2004-11-01 2006-06-29 Palu Afa K Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US20070237848A1 (en) * 2005-12-21 2007-10-11 Brad Rawson MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US20080226758A1 (en) * 2006-11-28 2008-09-18 Shixin Deng Lipoxygenase and Cyclooxygenase Inhibition
US20080213415A1 (en) * 2007-02-08 2008-09-04 Palu Afa K Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
PT103714B (pt) 2007-04-11 2020-07-28 73100 - Setenta E Três Mil E Cem, Lda. Processo para a obtenção de um polímero à base de galactose
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
US8748123B2 (en) 2009-12-15 2014-06-10 73100-Setenta e Tres Mil e Cem, Lda. Fucose-containing bacterial biopolymer
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670523A (de) * 1964-10-09
FR2513518A1 (fr) * 1981-09-29 1983-04-01 Tubery Pierre Polysaccharide extrait du gnidia kraussiana, preparation et usages therapeutiques
HU188311B (en) * 1982-03-04 1986-04-28 Szendrei,Kalman,Hu Process for producing biologically active polisaccharide concentrates and pharmaceutical compositions containing them as active agents

Also Published As

Publication number Publication date
ES2060666T3 (es) 1994-12-01
ATE98264T1 (de) 1993-12-15
IL86881A0 (en) 1988-11-30
JPS6431801A (en) 1989-02-02
EP0304347A2 (de) 1989-02-22
DK377888D0 (da) 1988-07-07
DK377888A (da) 1989-01-11
US5110803A (en) 1992-05-05
US4948785A (en) 1990-08-14
EP0304347B1 (de) 1993-12-08
FR2617848A1 (fr) 1989-01-13
EP0304347A3 (en) 1989-03-08
DE3886134T2 (de) 1994-04-21
DE3886134D1 (de) 1994-01-20
JPH0657721B2 (ja) 1994-08-03
BR8803442A (pt) 1989-01-31
FR2617848B1 (fr) 1990-01-05

Similar Documents

Publication Publication Date Title
IL86881A (en) Polysaccharides extracted from plants,their preparation and pharmaceutical compositions containing them
ATE35418T1 (de) Oligosaccharide mit selektiver, antikoagulierender wirkung.
AU2764592A (en) Beta -1,3-glucan polysaccharides, compositions, and their preparation and uses
FR2594438B1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
NL191308C (nl) Gelyofiliseerd, na oplossing injecteerbaar preparaat dat een antracycline-glycoside bevat, alsmede werkwijze voor de bereiding van een injecteerbare oplossing van een antracycline-glycoside.
NZ222251A (en) Hydrogenated avermectins and milbemycins, and parasiticidal compositions
AU6210698A (en) Carbohydrate mixture
IL88363A0 (en) Fluorocytidine derivatives,their production and pharmaceutical compositions containing them
EP0165726A3 (de) Darmmicroflora-Verbesserungsmittel
EP0077377A4 (de) Anticyclinglukosidzusammensetzungen, deren verwendung und herstellung.
DK0561089T3 (da) Hypocariogen hydrogeneret saccharidsammensætning samt fremgangsmåde til fremstilling og anvendelse af denne sammensætning.
AU6479790A (en) L-sugar laxatives
DE3168681D1 (en) D-homo steroids, their utilization and preparation and pharmaceutical compositions containing them
ZA856804B (en) Membrane polysaccharides which are useful,in particular,as a drug and process for preparation thereof
JPS5558097A (en) Novel polysaccharide extracted from influenza bacteria cell * production and pharmaceutical composition
FI853095L (fi) Foerfarande foer aotervinning av en gelbildande polysackarid, aotervunnen polysackarid och gel bildad daermed.
FI943242A0 (fi) Lääke munuais- ja maksatauteihin
FR2595697B1 (fr) Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
IL57129A0 (en) 6,7-benzomorphan derivatives their production and pharmaceutical compositions containing them
EG14833A (en) Nouveaux derives de decahydroquinoleinol,leur procede de preparation ainsi que leur applications en therapeutique
DE69111119T2 (de) Durch Fermentation hergestellte Polysaccharide.
DE59009626D1 (de) Basische Polysaccharide.
Yankina et al. Immunochemical analysis of oligosaccharide fragments of Shigella flexneri O-specific polysaccharides.
YU87989A (en) Process for altering pectine extract to standardized liquid pectins with 100, 130 and 150 percent gelling

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees